3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year
It's been a banner year for anyone who started 2017 holding shares of AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), XOMA Corporation (NASDAQ: XOMA), or Dynavax Technologies Corporation (NASDAQ: DVAX). All three of these stocks have risen more than 400% this year, and there are still a couple of months to go.
You should never buy stocks just because they're going up, but understanding why they spiked can help you decide if there's more upside ahead. Here's a closer look at what lit a fire under these rockets, and what needs to happen for their respective rallies to continue.
Image source: Getty Images.
Source: Fool.com
Novartis AG ADR Aktie
94,20 €
-0,84 %
Die Novartis AG ADR Aktie hat nicht genug Einschätzungen für ein klares Sentiment.
Das Community-Kursziel von 110 € für Novartis AG ADR deutet auf ein leicht positives Wachstumspotenzial gegenüber 94.2 € hin.
